Checkpoint Trends Limited

Equities

RUBRAME6

INE396H01019

Market Closed - Bombay S.E. Other stock markets 11:00:57 02/07/2024 BST			5-day change	1st Jan Change
8.82 ^INR	-2.00%		-4.96%	+90.09%

05-25	Checkpoint Trends Limited Announces Cessation of Sunil Khandalwal as Managing Director, with Effect from May 27, 2024	CI
05-25	Checkpoint Trends Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	CI

Gopal Marathe Resigns as Director of Rubra Medicaments

July 07, 2017 at 11:30 am

Gopal Marathe has resigned as director on the board of Rubra Medicaments. Marathe had joined the company in 2015 as its independent non-executive director.

Latest news about Checkpoint Trends Limited

Checkpoint Trends Limited Announces Cessation of Sunil Khandalwal as Managing Director, with Effect from May 27, 2024	05-25	CI
Checkpoint Trends Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	05-25	CI
Checkpoint Trends Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	02-07	CI
Checkpoint Trends Limited Announces Resignation of Komal Behl, Company Secretary	01-25	CI
Checkpoint Trends Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	11-07	CI
Checkpoint Trends Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	11/08/23	CI
Checkpoint Trends Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023	26/05/23	CI
Checkpoint Trends Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	13/02/23	CI
Checkpoint Trends Limited Announces Company Secretary Changes	07/12/22	CI
Checkpoint Trends Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	10/11/22	CI
Rubra Medicaments Limited Reports Earnings Results for the First Quarter Ended June 30, 2022	11/08/22	CI
Rubra Medicaments Limited Reports Earnings Results for the Full Year Ended March 31, 2022	25/05/22	CI
Rubra Medicaments Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2022	25/05/22	CI
Rubra Medicaments Gets Board Approval to Change Name	04/03/22	MT
Rubra Medicaments Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021	11/02/22	CI
Rubra Medicaments' Net Profit Soars in Fiscal Q2	11/11/21	MT
Rubra Medicaments Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021	11/11/21	CI
Rubra Medicaments Limited Reports Earnings Results for the First Quarter Ended June 30, 2021	13/08/21	CI
Rubra Medicaments Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2021	29/06/21	CI
Rubra Medicaments Limited Appoints Harish Surve as Independent Director	15/04/21	CI
Rubra Medicaments Limited Reports Earnings Results for the Third Quarter Ended December 31, 2020	12/02/21	CI
Rubra Medicaments Limited Reports Earnings Results for the Second Quarter Ended September 30, 2020	12/11/20	CI
Rubra Medicaments Limited Announces Appointment of Ms. Ritu Chhatani as Company Secretary and Compliance Officer	21/09/20	CI
Rubra Medicaments Limited Announces the Resignation of Manish Gandhi from the Post of Director	12/09/20	CI
Rubra Medicaments Limited Reports Earnings Results for the First Quarter Ended June 30, 2020	01/09/20	CI